3.9 Review

Malaria

Journal

JOURNAL OF THE ROYAL ARMY MEDICAL CORPS
Volume 159, Issue 3, Pages 158-166

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/jramc-2013-000112

Keywords

-

Ask authors/readers for more resources

Malaria is a life-threatening disease, with its largest impact being due to Plasmodium falciparum infection in Africa. Military populations continue to be at a high risk of malaria and reported case series have frequently revealed poor compliance with preventative measures. The symptoms of malaria are non-specific and its management depends on awareness of the diagnosis and early recognition and treatment. This is aided by new and simple rapid diagnostic tests, but these should not replace the examination of blood films if these are available. Artemisinin combination therapy provides a more rapid and dependable cure of uncomplicated P falciparum infection, with artesunate now being the drug of choice in severe infection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pharmacology & Pharmacy

An Open Label, Adaptive, Phase 1 Trial of High-Dose Oral Nitazoxanide in Healthy Volunteers: An Antiviral Candidate for SARS-CoV-2

Lauren E. Walker, Richard FitzGerald, Geoffrey Saunders, Rebecca Lyon, Michael Fisher, Karen Martin, Izabela Eberhart, Christie Woods, Sean Ewings, Colin Hale, Rajith K. R. Rajoli, Laura Else, Sujan Dilly-Penchala, Alieu Amara, David G. Lalloo, Michael Jacobs, Henry Pertinez, Parys Hatchard, Robert Waugh, Megan Lawrence, Lucy Johnson, Keira Fines, Helen Reynolds, Timothy Rowland, Rebecca Crook, Emmanuel Okenyi, Kelly Byrne, Pavel Mozgunov, Thomas Jaki, Saye Khoo, Andrew Owen, Gareth Griffiths, Thomas E. Fletcher

Summary: Repurposing the drug nitazoxanide may provide effective antiviral concentrations in COVID-19 patients, with the medication showing good safety and tolerability in healthy adult participants. This has led to the initiation of a phase Ib/IIa study in patients with COVID-19.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)

Letter Infectious Diseases

Implementation study of SARS-CoV-2 antigen lateral flow tests in men's professional (Premiership) rugby union sports squads in England during the COVID-19 pandemic

Lorna S. Finch, Adrian Harris, Catherine Lester, Dawn Veal, Karen Jones, Jamie Fulton, Lewis Jones, Matt Lee, Tony Walker, Mike Rossiter, Matt Cross, Simon Kemp, Tom Fletcher, Emily R. Adams

JOURNAL OF INFECTION (2022)

Article Infectious Diseases

Molnupiravir versus placebo in unvaccinated and vaccinated patients with early SARS-CoV-2 infection in the UK (AGILE CST-2): a randomised, placebo-controlled, double-blind, phase 2 trial

Saye H. Khoo, Richard FitzGerald, Geoffrey Saunders, Calley Middleton, Shazaad Ahmad, Christopher J. Edwards, Dennis Hadjiyiannakis, Lauren Walker, Rebecca Lyon, Victoria Shaw, Pavel Mozgunov, Jimstan Periselneris, Christie Woods, Katie Bullock, Colin Hale, Helen Reynolds, Nichola Downs, Sean Ewings, Amanda Buadi, David Cameron, Thomas Edwards, Emma Knox, I'ah Donovan-Banfield, William Greenhalf, Justin Chiong, Lara Lavelle-Langham, Michael Jacobs, Josh Northey, Wendy Painter, Wayne Holman, David G. Lalloo, Michelle Tetlow, Julian A. Hiscox, Thomas Jaki, Thomas Fletcher, Gareth Griffiths

Summary: This study aimed to evaluate the efficacy and safety of molnupiravir in patients with COVID-19 who have been vaccinated or unvaccinated. The results suggest that molnupiravir might have antiviral activity against SARS-CoV-2 infection.

LANCET INFECTIOUS DISEASES (2022)

Article Infectious Diseases

Air and surface sampling for monkeypox virus in a UK hospital: an observational study

Susan Gould, Barry Atkinson, Okechukwu Onianwa, Antony Spencer, Jenna Furneaux, James Grieves, Caroline Taylor, Iain Milligan, Allan Bennett, Tom Fletcher, Jake Dunning

Summary: This study investigated environmental contamination of monkeypox virus in isolation rooms of symptomatic patients at a hospital in London, UK. The findings revealed widespread surface contamination and presence of the virus in the air, indicating the potential transmission risk of the virus in healthcare settings. The results highlight the importance of cleaning protocols, personal protective equipment, and procedures to prevent and control the spread of the virus.

LANCET MICROBE (2022)

Article Infectious Diseases

Clinical features and management of individuals admitted to hospital with monkeypox and associated complications acrossthe UK: a retrospective cohort study

Douglas L. Fink, Helen Callaby, Akish Luintel, William Beynon, Helena Bond, Eleanor Y. Lim, Effrossyni Gkrania-Klotsas, Jospeh Heskin, Margherita Bracchi, Balram Rathish, Iain Milligan, Geraldine O'Hara, Stephanie Rimmer, Joanna R. Peters, Lara Payne, Nisha Mody, Bethany Hodgson, Penny Lewthwaite, Rebecca Lester, Stephen D. Woolley, Ann Sturdy, Ashley Whittington, Leann Johnson, Nathan Jacobs, John Quartey, Brendan A. Payne, Stewart Crowe, Ivo A. M. Elliott, Thomas Harrison, Joby Cole, Katie Beard, Tomas-Paul Cusack, Imogen Jones, Rishi Banerjee, Tommy Rampling, Jake Dunning

Summary: The 2022 global mpox outbreak has been unprecedented, with over 67,000 cases reported in non-endemic countries. Although mortality is rare, hospital admission is relatively common. This study found that males, white ethnicity, and HIV-infected patients were more likely to be hospitalized, and severe pain and secondary bacterial infection were the main reasons for admission.

LANCET INFECTIOUS DISEASES (2023)

Article Multidisciplinary Sciences

Characterisation of SARS-CoV-2 genomic variation in response to molnupiravir treatment in the AGILE Phase IIa clinical trial

I'ah Donovan-Banfield, Rebekah Penrice-Randal, Hannah Goldswain, Aleksandra M. Rzeszutek, Jack Pilgrim, Katie Bullock, Geoffrey Saunders, Josh Northey, Xiaofeng Dong, Yan Ryan, Helen Reynolds, Michelle Tetlow, Lauren E. Walker, Richard FitzGerald, Colin Hale, Rebecca Lyon, Christie Woods, Shazaad Ahmad, Dennis Hadjiyiannakis, Jimstan Periselneris, Emma Knox, Calley Middleton, Lara Lavelle-Langham, Victoria Shaw, William Greenhalf, Thomas Edwards, David G. Lalloo, Christopher J. Edwards, Alistair C. Darby, Miles W. Carroll, Gareth Griffiths, Saye H. Khoo, Julian A. Hiscox, Thomas Fletcher

Summary: This study investigates the impact of molnupiravir treatment on the genomic changes in SARS-CoV-2 and finds that it significantly increases the transition:transversion mutation ratio without causing specific resistance mutations.

NATURE COMMUNICATIONS (2022)

Article Public, Environmental & Occupational Health

COVID-19 risk, attitudes and behaviour study (CRAB study): A knowledge, attitudes, and practise qualitative study of COVID-19 in the Royal Navy

Stephen D. D. Woolley, Robert Chambers, Jonathan R. B. Bishop, Amy Logan, Peter McMillan, Thomas E. E. Fletcher, Miriam Taegtmeyer, Matthew K. K. O'Shea

Summary: This study investigated the knowledge, attitudes, and practises of Royal Navy personnel in relation to COVID-19 prevention. The findings revealed that male participants perceived COVID-19 as less serious, while BAME ethnicity rated it as more serious. Non-adherence to COVID-19 prevention measures was significantly influenced by colleagues' non-adherence among both vaccinated and vaccine-hesitant individuals. The Defence Medical Services were the most trusted source of vaccine information.

FRONTIERS IN PUBLIC HEALTH (2023)

Letter Public, Environmental & Occupational Health

Longitudinal mpox virus surface sampling in an outpatient setting

B. Atkinson, A. Spencer, O. Onianwa, J. Furneaux, J. Grieves, I. Nicholls, S. Gould, T. Fletcher, J. Dunning, A. M. Bennett, S. Patel, D. Asboe, G. Whitlock

JOURNAL OF HOSPITAL INFECTION (2023)

Review Infectious Diseases

Standard of care for viral haemorrhagic fevers (VHFs): a systematic review of clinical management guidelines for high-priorityVHFs

Ishmeala Rigby, Melina Michelen, Andrew Dagens, Vincent Cheng, Dania Dahmash, Eli Harriss, Eika Webb, Erhui Cai, Samuel Lipworth, Alexandra Oti, Valeria Balan, Helen Piotrowski, Robert Nartowski, Amanda Rojek, Helen Groves, Peter Hart, Muge Cevik, Henry Kyobe Bosa, Lucille Blumberg, Tom E. Fletcher, Peter W. Horby, Shevin Jacob, Louise Sigfrid

Summary: The Sudan virus disease outbreak in Uganda in 2022 highlighted the lack of effective clinical management guidelines for viral haemorrhagic fevers (VHFs). A systematic review identified 32 guidelines, with the majority being of low quality and lacking supporting evidence. The inconsistent and incomplete guidance on supportive care and therapeutics poses risks to patients and challenges for clinicians. It is recommended to establish a standard living guideline framework and invest in trials to improve the quality and applicability of guidelines, as well as identify optimal treatment strategies and affordable interventions for VHFs.

LANCET INFECTIOUS DISEASES (2023)

Article Public, Environmental & Occupational Health

The 2022 monkeypox outbreak: A UK military perspective

S. D. Woolley, M. Dermont, M. Adam, S. J. C. Pallet, N. Reece, N. Hoysal, G. Holden, K. K. Attridge, T. E. Fletcher, M. K. O'Shea, E. J. Hutley, E. D. Nicol, L. E. Lamb

Summary: The UK Defence Medical Services have been collaborating closely with the Defence Public Health Network (DPHN) and military infection clinicians to provide rapid advice and recommendations for managing patients with monkeypox and other high consequence infectious diseases. This interdisciplinary collaboration extends to the UK National Health Service (NHS) and the UK Health Security Agency (UKHSA), allowing for a dynamic exchange of expertise and development of guidelines. The close cooperation between civilian and military authorities in managing the current outbreak is also highlighted.

TRAVEL MEDICINE AND INFECTIOUS DISEASE (2023)

Article Chemistry, Analytical

Development and validation of an LC-MS/MS method for quantification of favipiravir in human plasma

Elizabeth Challenger, Sujan Dilly Penchala, Colin Hale, Richard Fitzgerald, Lauren Walker, Helen Reynolds, Justin Chiong, Tom Fletcher, Saye Khoo, Laura Else

Summary: Favipiravir is a broad-spectrum antiviral that selectively inhibits viral RNA-dependent RNA polymerase and has been investigated as a potential therapeutic for SARS-CoV-2 infection. A validated liquid chromatography tandem mass spectrometry method has been developed for quantifying Favipiravir in human plasma. The method is precise, accurate, and the drug shows high stability.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2023)

Article Medical Informatics

Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

Fiina Narhi, S. Ramani Moonesinghe, Susan D. Shenkin, Thomas M. Drake, Rachel H. Mulholland, Cara Donegan, Jake Dunning, Cameron J. Fairfield, Michelle Girvan, Hayley E. Hardwick, Antonia Ho, Gary Leeming, Jonathan S. Nguyen-Van-Tam, Riinu Pius, Clark D. Russell, Catherine A. Shaw, Rebecca G. Spencer, Lance Turtle, Peter J. M. Openshaw, J. Kenneth Baillie, Ewen M. Harrison, Malcolm G. Semple, Annemarie B. Docherty

Summary: The study evaluated the clinical implementation of corticosteroids in COVID-19 patients in the UK and found that patients older than 70, those with chronic neurological diseases and dementia, as well as pregnant women, were less likely to receive corticosteroids. This reflects potential inequalities in access to life-saving care among certain patient groups.

LANCET DIGITAL HEALTH (2022)

Article Medicine, Research & Experimental

Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2

Elena Mitsi, Jesus Reine, Britta C. Urban, Carla Solorzano, Elissavet Nikolaou, Angela D. Hyder-Wright, Sherin Pojar, Ashleigh Howard, Lisa Hitchins, Sharon Glynn, Madlen C. Farrar, Konstantinos Liatsikos, Andrea M. Collins, Naomi F. Walker, Helen C. Hill, Esther L. German, Katerina S. Cheliotis, Rachel L. Byrne, Christopher T. Williams, Ana Cubas-Atienzar, Tom E. Fletcher, Emily R. Adams, Simon J. Draper, David Pulido, Rohini Beavon, Christian Theilacker, Elizabeth Begier, Luis Jodar, Bradford D. Gessner, Daniela M. Ferreira

Summary: This study investigated the relationship between SARS-CoV-2 and Streptococcus pneumoniae in different populations, and found that pneumococcal infection reduces host immune responses to the virus.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Article Multidisciplinary Sciences

SARS-CoV-2 viability on sports equipment is limited, and dependent on material composition

Thomas Edwards, Grant A. Kay, Ghaith Aljayyoussi, Sophie Owen, Andy R. Harland, Nicholas S. Pierce, James D. F. Calder, Tom E. Fletcher, Emily R. Adams

Summary: Experimental studies have shown that there is a rapid reduction in the amount of viable SARS-CoV-2 virus on sports equipment after a short time period, and certain materials like tennis balls and cricket equipment have a lower risk of virus transmission. Therefore, sports equipment is unlikely to be a major cause for the transmission of SARS-CoV-2. These findings have important policy implications during the pandemic and may lead to the implementation of additional infection control measures to reduce the risk of SARS-CoV-2 transmission.

SCIENTIFIC REPORTS (2022)

Article Respiratory System

Prospective validation of the 4C prognostic models for adults hospitalised with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol

Stephen R. Knight, Rishi K. Gupta, Antonia Ho, Riinu Pius, Iain Buchan, Gail Carson, Thomas M. Drake, Jake Dunning, Cameron J. Fairfield, Carrol Gamble, Christopher A. Green, Sophie Halpin, Hayley E. Hardwick, Karl A. Holden, Peter W. Horby, Clare Jackson, Kenneth A. Mclean, Laura Merson, Jonathan S. Nguyen-Van-Tam, Lisa Norman, Piero L. Olliaro, Mark G. Pritchard, Clark D. Russell, Catherine A. Shaw, Aziz Sheikh, Tom Solomon, Cathie Sudlow, Olivia Swann, Lance C. W. Turtle, Peter J. M. Openshaw, J. Kenneth Baillie, Annemarie Docherty, Malcolm G. Semple, Mahdad Noursadeghi, Ewen M. Harrison

Summary: This study prospectively validated two risk scores for predicting mortality and in-hospital deterioration among adults hospitalized with COVID-19 in the UK. The 4C Mortality and 4C Deterioration scores demonstrated consistent discrimination across all NHS regions and stable calibration during the second wave of the pandemic. These risk stratification models can continue to inform clinical decision making for COVID-19 patients.

THORAX (2022)

No Data Available